Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,105.98
(
-0.73%
)
News Focus
News Focus
Post# of 824154
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

HyGro

Send PM Follow Ignore
Followers 24
Posts 4180
Boards Moderated 0
Alias Born 12/18/2019

HyGro

Re: biosectinvestor post# 508765

Monday, 08/29/2022 1:06:02 PM

Monday, August 29, 2022 1:06:02 PM

Post# of 824154
There are so many arguments against NWBO's Phase 3 trial. The evidence is questionable with post hoc trial redesign, data dredged recurrent GBM, confounded OS data questions validity, still unanswered recruiting issues that stopped the trial, etc.

It will be had to see regulators buying such dubious trial.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News